Prognosis of Hodgkin’s lymphoma
Although the term Hodgkin’s lymphoma has a very negative connotation in the general population, the prognosis for Hodgkin’s lymphoma is better than expected. After initiation of therapy, some side effects occur initially that strongly impair the quality of life for the duration of the therapy, but these can be alleviated with supportive measures. Overall, Hodgkin’s lymphoma has a very good prognosis after adequate therapy compared to most other cancers, especially in children.
For example, 80-90% of the patients are still alive 5 years after the end of therapy, in children more than 90%. The probability of recurrence can be reduced by a recurrence therapy, thus further improving the prognosis. However, it must be said that the lifelong risk of further tumors is increased.
Life expectancy for Hodgkin’s lymphoma
The life expectancy of a patient with Hodgkin’s lymphoma depends on a quick diagnosis and a good therapy. Untreated, the average life expectancy after diagnosis is 1.5 years, which, however, is greatly increased by the latest therapeutic methods. Once the disease is cured, a normal life expectancy can be assumed. Statistically, a cured Hodgkin’s patient thus has an almost normal life expectancy, which is only affected by the risk of second malignancies.
All articles in this series:
